SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a - 16 OR 15d - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of July, 2007
SkyePharma PLC, 105 Piccadilly, London W1J 7NJ England
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______
SkyePharma PLC ("the Company") Notification of Interests of Directors The Company was informed on 11 July 2007 by Jean-Charles Tschudin, Non-Executive Director of SkyePharma PLC, that on 6 July 2007 he had purchased 100,000 Ordinary Shares in the Company at a price of 25.7 pence per share. The shares are registered in the name of Jean-Charles Tschudin. As a result of the transaction Mr Tschudin now has a beneficial interest in 100,000 Ordinary Shares in the Company which represents 0.01% of the Issued Share Capital of the Company. - ends -
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By: /s/ John Murphy
Name: John Murphy
Title: Company Secretary
Date: July 11, 2007